Cancer profiling means getting aware of the cancer profile of a patient and recognizing any chromosomal changes that can assist a doctor direct his patients during a methodical treatment program with a higher probability of success.
This helps doctors exclude those treatments that are not expected to be successful, thus reducing the treatment course of action. The worldwide cancer profiling market is anticipated to expand by 2018 and will rise at a CAGR of 18 percent.
It is driven forward by the increasing number of cancer cases across the globe. Developments in technology, to spot the right reason of the condition, are also developing the cancer profiling market.